Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow.

<p><strong>BACKGROUND:</strong><em>Plasmodium vivax</em> malaria remains a major public health burden in Myanmar. Resistance to chloroquine (CQ), the first-line treatment for <em>P. vivax</em>, has been reported in the country and has potential to undermine...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Htun, M, Mon, N, Aye, K, Hlaing, C, Kyaw, M, Handayuni, I, Trimarsanto, H, Bustos, D, Ringwald, P, Price, R, Auburn, S, Thriemer, K
Fformat: Journal article
Iaith:English
Cyhoeddwyd: BioMed Central 2017

Eitemau Tebyg